Lei Xiao

Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus

Xuexiao Jin, Qin Xu, Chengfei Pu et al. · Cellular and Molecular Immunology · 2020 · 196 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Potent Anti-leukemia Activities of Chimeric Antigen Receptor–Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia

Yongxian Hu, Zhao Wu, Yi Luo et al. · Clinical Cancer Research · 2016 · 134 citations

Life Sciences, Oncology, Pharmacology +17

Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Adverse Effects of Chimeric Antigen Receptor T Cell Therapy in Patients with Non-Hodgkin Lymphoma

Jiasheng Wang, Yongxian Hu, Shuye Yang et al. · Biology of Blood and Marrow Transplantation · 2019 · 131 citations · Full text

Medicine, Immunology, Oncology +16

Donor‐derived<scp>CD</scp>19‐targeted T cell infusion induces minimal residual disease‐negative remission in relapsed B‐cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation

Yu‐Hong Chen, Yifei Cheng, Pan Suo et al. · British Journal of Haematology · 2017 · 103 citations · Full text

Medicine, Hematology, Immunology +16

Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study

Houli Zhao, Jieping Wei, Guoqing Wei et al. · Journal of Hematology & Oncology · 2020 · 83 citations · Full text

Medicine, Hematology, Oncology +16